Ozym (Pancreas Powder From Porcine)

Pancreas Powder, the active ingredient in Ozym, is a biological product presented as a powder for oral use. It provides digestive enzymes that aid in the breakdown of nutrients in patients with exocrine pancreatic insufficiency, particularly in adults and children who require enzyme supplementation. GNH USA supplies Ozym as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.

GNH USA supplies Ozym as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.

Ozym is a pancreatic enzyme preparation that acts on the digestive system to improve nutrient absorption in several clinical contexts.

- Exocrine pancreatic insufficiency: Improves digestion of fats, proteins and carbohydrates. - Cystic fibrosis related pancreatic dysfunction: Enhances nutrient absorption and reduces steatorrhea. - Post‑surgical pancreatic resection: Supports digestive function after removal of pancreatic tissue. - Chronic pancreatitis: Aids in managing malabsorption associated with chronic inflammation. - Pancreatic cancer supportive care: Helps maintain nutritional status during oncologic treatment.

Adverse reactions to porcine pancreas powder are generally related to the gastrointestinal tract and hypersensitivity.

Common Side Effects: - Mild abdominal discomfort: Transient stomach ache or cramping. - Flatulence: Increased intestinal gas production. - Diarrhea: Loose stools, often mild and self‑limiting. - Nausea: Feeling of queasiness without vomiting. - Constipation: Reduced bowel movements in some patients. - Taste alteration: Temporary metallic or unpleasant taste.

Serious or Rare Side Effects: - Severe allergic reaction: Rash, itching, swelling, or anaphylaxis. - Pancreatitis exacerbation: Worsening of pancreatic inflammation. - Respiratory distress: Shortness of breath linked to hypersensitivity. - Persistent vomiting: Inability to retain oral intake. - Foul‑smelling stool: Marked steatorrhea indicating malabsorption. - Serum electrolyte imbalance: Rare disturbances in potassium or calcium levels.

When using Ozym, clinicians should consider several safety and handling measures.

- Allergy assessment: Verify no known allergy to porcine proteins. - Monitoring: Observe for signs of gastrointestinal intolerance or allergic reaction. - Dose adjustment: Tailor dosage based on clinical response and nutritional status. - Concomitant therapy: Review other medications that may affect digestion or absorption. - Pregnancy and lactation: Use only if clearly needed; weigh potential benefits against risks. - Store at ambient temperature: Keep below 25°C in the original container, protect from moisture and direct sunlight.

Pancreas powder may interact with other agents that influence gastrointestinal function or drug absorption.

Major Interactions (Avoid): - Proton pump inhibitors: May reduce enzyme activation by increasing gastric pH. - Antacids containing aluminum or magnesium: Can bind enzymes and diminish efficacy.

Moderate Interactions (Monitor Closely): - Oral anticoagulants: Altered absorption may affect INR stability. - Lipid‑lowering agents (e.g., orlistat): Compete for the same intestinal site, potentially reducing fat digestion. - Antibiotics (e.g., tetracycline): May chelate with calcium‑containing formulations and lower bioavailability. - Diabetes medications: Improved carbohydrate digestion can modify glycemic control. - Vitamin supplements: High‑dose fat‑soluble vitamins may require dosage adjustment.